Condition: Severe Aplastic Anemia · Aplastic Anaemia · Hematopoietic Cell Transplant · Sponsor: Peking University People's Hospital
The goal of this prospective, multicenter, single arm observational study is to evaluate the efficacy and safety of the BFCA regimen in ≥ 40 years old SAA patients undergoing haplo-HSCT.
This description comes directly from the study's public registry record.
Tingting Han · 8601088326666 · htt1984.love@163.com
Always discuss trial participation with your own doctor first.
| Peking Universtiy Peoples' Hospital | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07586735